BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23018342)

  • 1. Thrombolysis in an ischemic stroke patient on dabigatran anticoagulation: a case report.
    Marrone LC; Marrone AC
    Cerebrovasc Dis; 2012; 34(3):246-7. PubMed ID: 23018342
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute ischemic stroke and new anticoagulants -- how to act in the acute phase of stroke?
    Marrone LC; Marrone AC
    Cerebrovasc Dis; 2013; 35(1):91. PubMed ID: 23429003
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran.
    De Smedt A; De Raedt S; Nieboer K; De Keyser J; Brouns R
    Cerebrovasc Dis; 2010; 30(5):533-4. PubMed ID: 20881383
    [No Abstract]   [Full Text] [Related]  

  • 4. What if a patient with atrial fibrillation and anticoagulant treatment is suffering from acute ischemia stroke?
    Zhou C; Zhu L; Wu J; Fang S
    Cerebrovasc Dis; 2013; 35(1):89-90. PubMed ID: 23429002
    [No Abstract]   [Full Text] [Related]  

  • 5. Proposed approach to thrombolysis in dabigatran-treated patients presenting with ischemic stroke.
    Kate M; Szkotak A; Witt A; Shuaib A; Butcher K
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1351-5. PubMed ID: 24406026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous thrombolysis in a stroke patient taking dabigatran.
    Lee VH; Conners JJ; Prabhakaran S
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):916.e11-2. PubMed ID: 22608344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.
    Casado Naranjo I; Portilla-Cuenca JC; Jiménez Caballero PE; Calle Escobar ML; Romero Sevilla RM
    Cerebrovasc Dis; 2011; 32(6):614-5. PubMed ID: 22133608
    [No Abstract]   [Full Text] [Related]  

  • 8. Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat.
    Kono S; Deguchi K; Omote Y; Yunoki T; Yamashita T; Kurata T; Ikeda Y; Abe K
    J Neurosci Res; 2014 Jan; 92(1):46-53. PubMed ID: 24265137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Good outcome after intravenous thrombolysis for acute stroke in a patient under treatment with dabigatran.
    Diogo C; Duarte J; Sobral S; Pestana P; Nzwalo H; Rita H; Sousa E Costa J
    Am J Emerg Med; 2014 Nov; 32(11):1435.e1-2. PubMed ID: 24881517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute stroke in patients on dabigatran: a survey of US stroke specialists.
    Rybinnik I; Mullen MT; Messe S; Kasner SE; Cucchiara B
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1312-6. PubMed ID: 23313461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous thrombolysis in a stroke patient taking dabigatran.
    Testai FD
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):894. PubMed ID: 22868184
    [No Abstract]   [Full Text] [Related]  

  • 12. Dilemma of indication for thrombolysis in a patient with acute ischemic stroke treated with a novel oral anticoagulant.
    Folyovich A; Varga V; Béres-Molnár KA; Vadasdi K; Bereczki D
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):580-2. PubMed ID: 23721623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute ischemic stroke treated with intravenous tissue plasminogen activator in a patient taking dabigatran with radiographic evidence of recanalization.
    Sangha N; El Khoury R; Misra V; Lopez G
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):917.e5-8. PubMed ID: 22683118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients.
    Takeuchi S; Wada K; Nagatani K; Otani N; Osada H; Nawashiro H
    Acta Neurochir (Wien); 2012 Jan; 154(1):87. PubMed ID: 22037979
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombolysis in capsular warning syndrome.
    Vivanco-Hidalgo RM; Rodriguez-Campello A; Ois A; Cucurella G; Pont-Sunyer C; Gomis M; Cuadrado-Godia E; Roquer J
    Cerebrovasc Dis; 2008; 25(5):508-10. PubMed ID: 18477844
    [No Abstract]   [Full Text] [Related]  

  • 16. Magnetic resonance imaging-guided thrombolysis in minor stroke.
    Desilles JP; Cho TH; Hermier M; Mechtouff-Cimarelli L; Derex L; Nighoghossian N
    Int J Stroke; 2011 Apr; 6(2):178. PubMed ID: 21371285
    [No Abstract]   [Full Text] [Related]  

  • 17. Transient ischemic attack after tissue plasminogen activator: aborted stroke or unnecessary stroke therapy?
    Uchino K; Massaro L; Hammer MD
    Cerebrovasc Dis; 2010; 29(1):57-61. PubMed ID: 19893313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous thrombolytic treatment in a patient with transient ischemic attack associated with mural carotid thrombi.
    Yaka E; Men S; Öztürk V; Kutluk K
    Clin Neurol Neurosurg; 2011 Jun; 113(5):416-8. PubMed ID: 21353383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroke thrombolysis in patients taking dabigatran.
    Jayathissa S; Gommans J; Harper P
    Intern Med J; 2013 Jul; 43(7):826-8. PubMed ID: 23841763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke.
    Pfeilschifter W; Bohmann F; Baumgarten P; Mittelbronn M; Pfeilschifter J; Lindhoff-Last E; Steinmetz H; Foerch C
    Ann Neurol; 2012 May; 71(5):624-33. PubMed ID: 22447744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.